Pharmacological Activity of Cb-103 in Haematological Malignancies - An Oral Pan-Notch Inhibitor With a Novel Mode of Action

Hematological Oncology - United Kingdom
doi 10.1002/hon.2437_28
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Simocyclinone D8, an Inhibitor of DNA Gyrase With a Novel Mode of Action

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
2005English

Antitumor Activity of a Novel Oral STAT3 Inhibitor YHO‐1701

Cancer Science
Cancer ResearchMedicineOncology
2020English

A Small-Molecule Oligosaccharyltransferase Inhibitor With Pan-Flaviviral Activity

Cell Reports
BiochemistryGeneticsMolecular Biology
2017English

A Novel Mode of Chaperone Action

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
2004English

A Novel Synthetic Flavonoid With Potent Antibacterial Properties: In Vitro Activity and Proposed Mode of Action

PLoS ONE
Multidisciplinary
2018English

Aggressive Haematological Malignancies

Virchows Archiv
MedicineForensic MedicinePathologyCell BiologyMolecular Biology
2017English

Phase I Study of S-Trans, Trans-Farnesylthiosalicylic Acid (Salirasib), a Novel Oral RAS Inhibitor in Patients With Refractory Hematologic Malignancies

Clinical Lymphoma, Myeloma and Leukemia
Cancer ResearchOncologyHematology
2015English

A Novel Dual PI3Kα/mTOR Inhibitor PI-103 With High Antitumor Activity in Non-Small Cell Lung Cancer Cells

International Journal of Molecular Medicine
MedicineGenetics
2009English

Probable Mode of Action of Oral Contraceptives.

BMJ
1965English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy